21 May 2013
Keywords: Daiichi Sankyo, Ranbaxy, R&D, Focus on generics, India, Japan
Article | 06 July 2010
Japanese drugmaker Daiichi Sankyo and its 64% owned Indian affiliate Ranbaxy Laboratories, as a part of its strategy to strengthen their ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 July 2010
20 May 2013
© 2013 thepharmaletter.com